Remove 2025 Remove Conditions Remove Media Remove Treatment
article thumbnail

Press Release: 1st Female Founded Psychedelic Biotech Coy Launches

Cannabis Law Report

Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. About Aphrodite Health. About The Conscious Fund.

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025. 1 Brightfield Group 2020.

Access 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First Female-founded Psychedelic Biotech Company Launches

Cannabis Law Report

Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments. Its portfolio includes leading companies in drug discovery, clinics, addiction programs, retreats, AI, technology, media and training. About Aphrodite Health. About The Conscious Fund.

article thumbnail

The benefits of CBD consumption 

The Joint Blog

While some are quick to criticize it and point out its allegedly adverse effects, habitual users swear by it as an often miracle cure for a plethora of conditions. Indeed, only in the United States, it is projected to hit $16 billion by 2025. Cannabis consumption is still a polarizing topic. The plant is indeed paradoxical.

article thumbnail

Thai Health Minister Heads Panel Discussion At Foreign Correspondents Club of Thailand To Color In Detail On Cannabis Legislation

Cannabis Law Report

Thus, his announcement created a big stir in the media, especially because the official Cannabis Act has not been passed as yet. But he warned that the licensing would need to be streamlined, and also that the potency of the drug needed to be tested regularly, especially due to the humid conditions in Asia. “But

article thumbnail

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank. Media: media@mymd.com. 646) 421-9523.

article thumbnail

Where Does The FDA Stand on CBD and CBD Products?

The Joint Blog

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. organic food market by 2025 is at $70.4 Cannabis has come a long way from being the taboo herb of decades past. CBD is everywhere these days. It has been predicted that the U.S CBD Products and the FDA The U.S.

CBD 33